Literature DB >> 22738690

The association between impaired collateral circulation and non-alcoholic fatty liver in patients with severe coronary artery disease.

Uğur Arslan1, Ibrahim Kocaoğlu, Mustafa Balcı, Serkan Duyuler, Ahmet Korkmaz.   

Abstract

BACKGROUND AND
PURPOSE: Coronary collateral circulation (CCC) has been demonstrated to be impaired in patients with type 2 diabetes mellitus which is characterized by insulin resistance. In this study, our purpose was to find out a possible relationship between CCC and non-alcoholic fatty liver disease (NAFLD), which is also characterized by insulin resistance, in non-diabetic patients with severe coronary artery disease.
METHODS: One hundred and fifty-one consecutive non-diabetic patients with stable angina pectoris who were found to have >95% stenosis of at least one major coronary artery were enrolled. Abdominal ultrasonography (USG) was performed after coronary angiography to determine the presence or absence of NAFLD.
RESULTS: According to Cohen-Rentrop method, 81 (53.7%) patients had good and 70 (46.3%) patients had poor collateral development. NAFLD was present in 98 patients (64.9% of study population) and more prevalent in patients with poor collateral development [58 of 70 patients (82.9%) vs. 40 of 81 patients (49.4%), p<0.001]. Mean Rentrop collateral score was significantly lower in patients with NAFLD (1.2±1.2 vs. 2.1±0.9, p<0.001). Shorter angina time, metabolic syndrome, presence of insulin resistance, less severe coronary artery disease, and female sex were also associated with poor collateral development. When the logistic regression analysis was performed using these factors, NAFLD was still significantly related to poor collateral development.
CONCLUSIONS: Presence of NAFLD is associated with poor coronary collateral development in non-diabetic patients with severe coronary artery disease independent from other variables, especially metabolic syndrome and insulin resistance. Which mechanisms play role in this association is needed to be cleared with further studies.
Copyright © 2012 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22738690     DOI: 10.1016/j.jjcc.2012.05.003

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  11 in total

Review 1.  Nonalcoholic fatty liver disease and cardiovascular disease.

Authors:  Hong Liu; Hong-Yun Lu
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Relationship between the prevalence and severity of non-alcoholic fatty liver disease and coronary artery disease: Findings from a cross-sectional study of a referral center in northeast Iran.

Authors:  Arash Gholoobi; Mehrnoosh Gifani; Aida Gholoobi; Saeed Akhlaghi; Masoud Pezeshki Rad; Vafa Baradaran Rahimi
Journal:  JGH Open       Date:  2022-04-27

Review 3.  Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Authors:  Stefano Ballestri; Amedeo Lonardo; Stefano Bonapace; Christopher D Byrne; Paola Loria; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

4.  Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka.

Authors:  Nilanka Perera; Jegarajah Indrakumar; Waruni Vijitha Abeysinghe; Vihangi Fernando; W M C K Samaraweera; Jayamal Sanjaya Lawrence
Journal:  BMC Cardiovasc Disord       Date:  2016-02-12       Impact factor: 2.298

5.  Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis.

Authors:  Rahul Sao; Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-07-05       Impact factor: 3.318

Review 6.  Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter.

Authors:  Stefan Chiriac; Carol Stanciu; Irina Girleanu; Camelia Cojocariu; Catalin Sfarti; Ana-Maria Singeap; Tudor Cuciureanu; Laura Huiban; Cristina Maria Muzica; Sebastian Zenovia; Robert Nastasa; Anca Trifan
Journal:  Can J Gastroenterol Hepatol       Date:  2021-01-12

Review 7.  Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury.

Authors:  Irina Gîrleanu; Anca Trifan; Laura Huiban; Cristina Muzîca; Oana Cristina Petrea; Ana Maria Sîngeap; Camelia Cojocariu; Stefan Chiriac; Tudor Cuciureanu; Irina Iuliana Costache; Carol Stanciu
Journal:  Life (Basel)       Date:  2022-07-12

8.  Predictors of coronary collaterals in patients with non ST-elevated acute coronary syndrome: the paradox of the leukocytes.

Authors:  Erhan Tenekecioglu; Mustafa Yılmaz; Kemal Karaagac; Adem Bekler; Burhan Aslan; Serafettin Demir; Mustafa Kuzeytemiz
Journal:  Cent Eur J Immunol       Date:  2014-04-17       Impact factor: 2.085

9.  Association between Nonalcoholic Fatty Liver Disease and Carotid Artery Disease in a Community-Based Chinese Population: A Cross-Sectional Study.

Authors:  Yu-Chen Guo; Yong Zhou; Xing Gao; Yan Yao; Bin Geng; Qing-Hua Cui; Ji-Chun Yang; Hong-Pu Hu
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

Review 10.  Relationship between non-alcoholic fatty liver disease and coronary heart disease.

Authors:  Ugur Arslan; Mustafa Yenerçağ
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.